A pharma giant is moving past one patent cliff — but another is already looming: Disappointing data highlights Novartis' challenge to build its next generation ...
cnbc.com/2026/10/30/novartis-remibrutinib-multiple-sclerosis.html
Roche beats revenue estimates, shares slip as copycats eat into Xolair sales: Swiss drugmaker Roche beat third-quarter sales expectations on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/roche-third-quarter-sales-slightly-beat-expectations-with-growth-across-2026-10-22/
STAT Oct 27
Paid articlePaywall Roche gets a lung cancer win with its KRAS drug divarasib: Roche drug, which inhibits G12C KRAS mutations in second-line advanced non-small cell lung cancer ...
statnews.com/2026/10/26/roche-kras-drug-divarasib-lung-cancer-treatment-win/
Why pharma giant Roche is putting German investments on hold: Germany’s bid to revive its struggling economy faces a fresh setback as a major pharmaceutical ...
euronews.com/2026/10/20/why-pharma-giant-roche-is-putting-german-investments-on-hold
Roche moves future Germany investments 'on hold': Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting policies ...
reuters.com/legal/litigation/roche-moves-future-germany-investments-on-hold-2026-10-19/
Key FactsRoche pauses future investments in Germany for now
Oct 19, 2026 · Reading time: ~45 sec.
Summary created with AI assistance · Source: reuters.com
Summary created with AI assistance · Source: reuters.com
- Roche is reviewing all future investments in Germany amid healthcare cost-cutting policies.
- Germany chief Daniel Steiners said the decisions were temporarily suspended and policymakers had destroyed much trust.
- Steiners called for a comprehensive strategy while criticizing short-term savings and additional burdens on industry.
- The planned expansion of the Penzberg site, worth more than €600 million, is not affected by the review.
We have put all future investment decisions in Germany on hold for the time being.— Daniel Steiners, head of Roche Germany, in an interview with Welt
STAT Oct 20
Paid articlePaywall Roche continues to look to China for new drugs: Today's biotech news includes AltruBio's ulcerative colitis drug data, Merck to buy Silence ...
statnews.com/2026/10/20/biotech-news-roches-15b-hunt-for-new-drugs-in-china/
Could “stable” asthma be masking ongoing disease activity? Explore this activity to rethink disease stability in moderate to severe asthma. A New Era in Airway Disease Management
The Gulf’s next economic transformation is a health one: The Gulf’s next economic transformation is a health one
arabnews.com/corporate-and-sponsored-content/the-gulfs-next-economic-transformation-is-a-health-one-3007126
Roche just bet up to $15B on China's cancer drug tech
Roche's massive licensing deal with Hansoh Pharmaceutical signals how aggressively Western ... Show more
Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion: Hansoh will receive $400 million upfront and keep rights to ... Show more
The Beauty Products Andrea Ámez Uses to the Last Drop: At The Cut, we chat all day long about the products we love — the ones so good they’ll make you hit that ...
thecut.com/article/andrea-amez-skin-care-routine-best-beauty-products.html
Public sector CEOs set to face performance pay and sanctions: Public Service Commissioner Sir Brian Roche says the stark black and white choice over whether MBIE ...
newsroom.co.nz/2026/10/15/public-sector-ceos-set-to-face-performance-pay-and-sanctions/
Roche licensed a Chinese biotech's obesity drug in a deal worth up to $1.16 billion: The Swiss drugmaker will pay up to $100 million upfront to license ... Show more
Biocon clears patent hurdle for breast cancer biosimilar Pebrilzo: Genentech patent settlement clears legal hurdles for Pebrilzo; competition and pricing will ...
business-standard.com/companies/news/biocon-pebrilzo-pertuzumab-biosimilar-genentech-patent-settlement-126101400326_1.html
STAT Oct 09
Paid articlePaywall Roche goes beyond licensing in deal with Chinese biotech: Today's biotech news includes: DOJ signals it will start scrutinizing drugmakers ...
statnews.com/2026/10/08/biotech-news-roche-goes-beyond-licensing-in-deal-with-chinese-biotech/
Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial
reuters.com/business/healthcare-pharmaceuticals/zealand-roches-obesity-drug-helps-patients-lose-up-92-weight-mid-stage-trial-2026-10-07/
Vision connects us to the world. On Health Awareness Day, we champion advancing clinical excellence in retinal diseases—driving innovation, early detection ... Show more
Retinal Diseases
Retinal Diseases
Explore new content focused on recognizing uncontrolled moderate to severe asthma and identifying when referral or treatment escalation may be appropriate ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
STAT Sep 29
Paid articlePaywall AstraZeneca invests $2 billion in Summit Therapeutics: Today's biotech news includes results for UniQure’s experimental Huntington’s gene therapy ...
statnews.com/2026/09/29/biotech-news-astrazeneca-invests-2-billion-in-summit-therapeautics/
STAT Sep 29
Paid articlePaywall Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more
statnews.com/pharmalot/2026/09/29/novo-licenses-obesity-pill-from-china-merck-pulls-antibiotic/
KitchenAid, Bose and Kérastase: The very best sales to shop this Prime Big Deal Day
theage.com.au/lifestyle/life-and-relationships/kitchenaid-bose-and-k-rastase-the-very-best-sales-to-shop-this-prime-big-deal-day-20260929-p60zta.html
People without kids should make this money move before it's too late, estate planning expert says
cnbc.com/2025/11/03/make-this-key-money-move-now-if-you-dont-have-kids-expert-says.html
Roche-owned Chugai Pharma to ramp up in-house output with 50% capex boost: TOKYO -- Chugai Pharmaceutical intends to invest around 100 billion yen ($635 million) ...
asia.nikkei.com/business/pharmaceuticals/roche-owned-chugai-pharma-to-ramp-up-in-house-output-with-50-capex-boost
Roche’s obesity drug boosts blood sugar control, drives 15.5 percent weight loss in mid-stage trial
arabnews.com/world/roches-obesity-drug-boosts-blood-sugar-control-drives-155-percent-weight-loss-in-mid-stage-trial-3002685
Barron's Sep 22
Paid articlePaywall Berkshire Buys Over $200 Million of Lennar Stock and Now Holds 10% of Big Home Builder
barrons.com/articles/berkshire-lennar-stock-price-buy-6bad1928
La Roche-Posay is back in India and I tried its cult classics: La Roche-Posay is finally back in India. I tried the cult French pharmacy brand’s bestselling ...
vogue.in/content/i-tried-the-french-pharmacy-legend-thats-finally-on-indian-shelves
Novo rivals Lilly, Merck, and Roche have all invested in AI, though it has largely been used to improve workplace productivity and design clinical trials ... Show more
San Juan Island’s lime kilns fueled fierce competition for decades: Long before it was a resort destination, the limestone industry shaped Roche Harbor ...
seattletimes.com/pacific-nw-magazine/san-juan-islands-lime-kilns-fueled-fierce-competition-for-decades/
Novartis investors turn spotlight on M&A after trial setbacks: Novartis investors are set to step up scrutiny of the Swiss group's dealmaking strategy after ...
reuters.com/legal/transactional/novartis-investors-turn-spotlight-ma-after-trial-setbacks-2026-09-11/
yicaiglobal.com Aug 28
China’s Duality Rises on Deal Worth Over USD1 Billion to Co-Develop Cancer Drugs With Roche Unit
yicaiglobal.com/news/chinas-duality-rises-on-deal-worth-over-usd1-billion-to-co-develop-cancer-drugs-with-roche-unit
Novartis Just Cruised Past A Buy Point Amid Its Roche, Sanofi Rivalry: Novartis stock surged early Tuesday after its experimental multiple sclerosis treatment ...
investors.com/news/technology/novartis-stock-multiple-sclerosis-treatment/
‘We were in our 40s when we married, so retirement planning came up early’ – how finance experts discuss money with their partners
independent.ie/business/money/we-were-in-our-40s-when-we-married-so-retirement-planning-came-up-early-how-finance-experts-discuss-money-with-their-partners/a/160754449.html
Advance your understanding of next-generation anti-VEGF therapies through expert-led discussions and the latest clinical evidence ... Show more
Retinal Diseases
Retinal Diseases
Singapore’s RIE2025 plan saw more business spending, more jobs created in R&D: Singapore’s RIE2025 plan boosts research and innovation with $28 billion ...
straitstimes.com/singapore/singapores-rie2025-plan-saw-more-business-spending-more-jobs-created-in-rd
Guidance gurus advise what to do if you miss your top CAO choice: Jess Casey, Education Correspondent, talks with career guidance experts Marian Roche and David ...
irishexaminer.com/news/arid-41902219.html
China's Hansoh Pharma posts 36% rise in first-half profit helped by innovative drug sales
reuters.com/business/healthcare-pharmaceuticals/hansoh-pharma-reports-36-rise-first-half-profit-helped-by-innovative-drug-sales-2026-08-26/
STAT Aug 25
Paid articlePaywall Pharmalittle: We’re reading about RFK Jr. vaccine disclosures, a Merck loss over Medicare prices, and more
statnews.com/pharmalot/2026/08/25/rfk-vaccine-disclosure-merck-court-loss-over-medicare/
Dividend darling Roche: Obesity deal - | Gubra comes into focus: Genentech sichert sich Lizenzrechte an Hanmis Adipositas-Wirkstoff HM17321 ...
deraktionaer.de/artikel/pharma-biotech/dividenden-liebling-roche-adipositas-deal-gubra-rueckt-in-den-fokus-20407319.html
People without kids should make this money move before it's too late, estate planning expert says
cnbc.com/2025/11/03/make-this-key-money-move-now-if-you-dont-have-kids-expert-says.html
Gain practical strategies for managing CRSwNP beyond repeated oral steroid use. Learn how current evidence can help identify uncontrolled disease ... Show more
A New Era in Airway Disease Management
A New Era in Airway Disease Management
STAT Aug 21
Paid articlePaywall Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more
statnews.com/pharmalot/2026/08/21/roche-genentech-investment-estrogen-patch-shortages/
Paid articlePaywall More than half of Gen Z redirected money away from investing and toward sports betting over the past year
marketwatch.com/story/more-than-half-of-gen-z-redirected-money-away-from-investing-and-toward-sports-betting-over-the-past-year-937a366c
Roche launches two new cyclospora tests as US outbreak widens: Roche said on Thursday it launched two new tests to detect cyclospora, as U.S ...
reuters.com/business/healthcare-pharmaceuticals/roche-launches-two-new-cyclospora-tests-us-outbreak-widens-2026-08-06/
Adani Ports, Radico, KFin among 6 top stock ideas for Aug by Motilal Oswal: Motilal Oswal Wealth Management Research Desk recommends 2 stocks each from the ...
business-standard.com/markets/news/adani-ports-radico-kfin-among-6-top-stock-ideas-for-aug-by-motilal-oswal-126080300065_1.html
Paid articlePaywall AI Today: Chronicling the disruptions and threats of AI on businesses, workers, finance and economies with analysis from Bloomberg’s global newsroom.
bloomberg.com/account/newsletters/ai-today
Dash Social Aug 04
.png)
6 Best Sunscreens for Oily Skin, Dermatologists-Approved 2026: We tested the best sunscreens for oily skin, recommended by dermatologists. Our top picks include ...
glamour.com/gallery/best-sunscreen-for-oily-skin
Paid articlePaywall The distraught brides 'left without a dress with their wedding day hanging in the balance'
manchestereveningnews.co.uk/news/greater-manchester-news/distraught-brides-left-without-dress-34366171
Paid articlePaywall Can AI Make Better Drugs? Not on Wall Street’s Timeline: The technology has arrived in the drug lab. But should investors pay up for it?
wsj.com/tech/ai/can-ai-make-better-drugs-not-on-wall-streets-timeline-98a50d9d
help.medscape.com Jul 15
A Comprehensive Eye Care Center: Are some of your approaches to retinal disease management outdated? Stay up to date with this forward-looking initiative.
medscape.org/advances/comprehensive-eye-care-center-2026a1000d6h
TG Therapeutics Stock Is On A Hot Streak: Why It's Up 70% And Climbing: TG Therapeutics stock is on a hot streak, climbing 70% in roughly the first six months of ...
investors.com/research/the-new-america/tg-therapeutics-stock-briumvi-myasthetia-gravis-subcutaneous/
Barron's Jun 08
Paid articlePaywall This Biotech Stock Is Up 11% on $2.3 Billion Roche Deal for Blood Cancer Drug: Nurix Therapeutics strikes an agreement with Roche to commercialize its lead asset ...
barrons.com/articles/nurix-therapeutics-stock-roche-cancer-drug-43b07f1e
Thanks to Nicola Willis and Brian Roche, I now get that I’m just human capital: Please replace me with AI, for my chief concern is productivity.
thespinoff.co.nz/politics/21-05-2026/thanks-to-nicola-willis-and-brian-roche-i-now-get-that-im-just-human-capital
Your Local Guardian May 29
Croydon's new civic mayor Mohammed Islam appointed: Councillor Mohammed Islam was officially named as Croydon’s new civic mayor at a ceremony during the ...
yourlocalguardian.co.uk/news/26147706.croydons-new-civic-mayor-mohammed-islam-appointed/
People without kids should make this money move before it's too late, estate planning expert says
cnbc.com/2025/11/03/make-this-key-money-move-now-if-you-dont-have-kids-expert-says.html
Billion-dollar deal: Roche relies on AI in diagnostics: Roche pays US$1.05 billion for PathAI to improve diagnostics with AI.
wallstreet-online.de/nachricht/20837951-roche-greift-ki-schatz-milliarden-deal-roche-diagnostik-ki
Paid articlePaywall Roche CEO Expects Pharma Portfolio to Deliver Sales Growth Through 2030: Roche’s diagnostics division is expected to deliver mid-to-high single-digit percentage ...
wsj.com/health/pharma/roche-ceo-expects-pharma-portfolio-to-deliver-sales-growth-through-2030-128588c4
5 Best Retinol Products for Beginners, Reviewed by Glamour: We tested the best retinol products for beginners, according to dermatologists and testers ...
glamourmagazine.co.uk/article/best-retinol-products-for-beginners
Kiran Mazumdar-Shaw’s niece Claire Mazumdar set to lead Biocon into its next growth era
indianexpress.com/article/business/claire-mazumdar-lead-biocon-growth-era-10675513/
Europe risks falling further behind in medicine race, warns Roche CEO: Europe risks falling further behind the United States and China in pharmaceutical research ...
reuters.com/legal/litigation/europe-risks-falling-further-behind-medicine-race-warns-roche-ceo-2026-04-23/
Roche sales down 5% as currency effects outweigh gains for haemophilia drug: Swiss drugmaker Roche's first-quarter sales dropped by 5%, it said on Thursday ...
reuters.com/business/healthcare-pharmaceuticals/roche-q1-sales-down-forex-effects-2026-04-23/
Energy shortages, economic pain still coming after Iran peace: strategist: Permabear David Roche says he thinks the world is facing a 10% oil and gas shortage ...
businessinsider.com/iran-war-world-recession-economic-outlook-oil-gas-supply-shock-2026-4
LookFantastic's £45 skincare bundle is worth £150 and features Medik8: LookFantastic's new Dermatological Edit is a nine-product skincare bundle with ...
kentlive.news/whats-on/shopping/look-fantastic-dermatological-edit-beauty-10931284
Grazia Apr 22
Noli Review: The New Way To Get Dermatologist-Approved Skincare: Noli is a clever way to shop dermatologist-approved skincare without needing to book an ...
graziadaily.co.uk/beauty-hair/skin/noli-skincare-review/
Eyes turn to Ireland in a bid for more research funding: Like New Zealand, Ireland’s research sector is heavily geared towards private investment – a potential ...
newsroom.co.nz/2026/04/20/eyes-turn-to-ireland-in-a-bid-for-more-research-funding/
Paid articlePaywall This study will tell you everything you need to know about how to be a successful investor
marketwatch.com/story/this-study-will-tell-you-everything-you-need-to-know-about-how-to-be-a-successful-investor-6c598944
Paid articlePaywall Global drug makers face pricing pressure as China targets affordable healthcare: As pharmaceutical firms navigate China’s aggressive pricing reforms ...
scmp.com/business/china-business/article/3349163/global-drug-makers-face-pricing-pressure-china-targets-affordable-healthcare
Walmart's new partnership brings iconic beauty brand to stores: Skincare enthusiasts will be thrilled with the retailer's latest partnership. Sources: Walmart ...
thestreet.com/retail/walmarts-new-partnership-brings-iconic-beauty-brand-to-stores
Ipswich Star Apr 04
The criminals jailed at Ipswich Crown Court this week: A burglar who stole a three-month-old puppy and six firearms during a break-in was among those jailed at ...
ipswichstar.co.uk/news/25993601.criminals-jailed-ipswich-crown-court-week/
China's Hansoh Pharmaceutical Group beats net profit expectations in 2025: China's Hansoh Pharmaceutical Group , a Roche partner, reported a 27% rise in annual ...
reuters.com/business/healthcare-pharmaceuticals/chinas-hansoh-pharmaceutical-group-beats-net-profit-expectations-2025-2026-03-29/
Can Swiss pharma giant Roche reshape the obesity market?: Swiss pharmaceutical firm Roche is investing billions in new obesity treatments in hopes of breaking ...
swissinfo.ch/eng/new-treatments/can-swiss-pharma-giant-roche-reshape-the-obesity-market/91193956
Explainer: why Roche’s supercomputer is a big deal: Pharma companies are racing to acquire microchips and achieve the most powerful AI capacity in the industry ...
swissinfo.ch/eng/ai-and-medicine/explainer-why-roches-supercomputer-is-a-big-deal/91154969
When will the new Manchester United stadium open? Red Devils offer update: Manchester United's new stadium plans are 'on track' but the new venue will not be ...
metro.co.uk/2026/03/25/will-new-manchester-united-stadium-open-red-devils-offer-update-27660566/